Navigation Links
Cardiogenesis Reports Fourth Quarter and Full Year 2010 Results
Date:3/9/2011

amily:Arial;font-size:8pt;">$
4,499

$  5,018LIABILITIES AND SHAREHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
359

$  127Accrued salaries and related

723

604Accrued liabilities

531

299Deferred revenue

684

744Note payable

111

88Current portion of capital lease obligations

  8

  9Total current liabilities

2,416

1,871Capital lease obligations, less current portion

  5

14Total liabilities

2,421

1,885Commitments and contingenciesShareholders' equity:Preferred stock:no par value; 5,000 shares authorized; none issued and outstanding

—Common stock:no par value; 75,000 shares authorized; 45,888 and 45,549 shares issued and outstanding, respectively

174,459

174,217Accumulated deficit

(172,381)

(171,084)Total shareholders' equity

2,078

3,133Total liabilities and shareholders' equity

$
4,499

$  5,018
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
2. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
3. Cardiogenesis Reports Third Quarter 2009 Results
4. Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010
5. Cardiogenesis (CGCP) Listing Upgraded to New OTCQB(TM) Market for All U.S. Registered and Reporting OTC Securities
6. Cardiogenesis Corporation to Report 2010 Second Quarter Results on August 4th
7. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
8. Cardiogenesis Enrolls First Two Patients in Its Feasibility Study of the PHOENIX® Combination Delivery System
9. Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd
10. Cardiogenesis Receives Research Award From Federal Government
11. Cardiogenesis Reports Third Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... paid the September 12, 2014, regular quarterly dividend payment of ... PDL as of September 5, 2014, the record date. ... manages a portfolio of patents and royalty assets, consisting ... and license agreements with various biotechnology and pharmaceutical companies. ...
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... Drug Transfer Systems to 2020" report to their ... hazardous to humans has been receiving increasing amounts of ... substances become more clearly understood. For caregivers and their ... of attempts to mitigate exposure to cytotoxic drugs is ...
(Date:9/15/2014)... -- Research and Markets has announced the addition ... Tests, 9th Edition" report to their offering. ... testing market and all of its segments, providing customers with ... For Business Planning. This is the ninth edition ... 2013 and early 2014. New entrants, new technologies have entered ...
Breaking Medicine Technology:PDL BioPharma Completes Regular Quarterly Dividend Payment 2Closed Drug Transfer Systems to 2020 2Closed Drug Transfer Systems to 2020 3The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... 17, 2011 Attorneys representing a group of U.S. citizens ... the drug thalidomide have filed a lawsuit in federal court ... show the drug was widely distributed in the United States. ... to respond to a number of Freedom of Information Act ...
... WASHINGTON, Nov. 17, 2011 The proliferation of brand ... generics to more expensive brands, will increase costs by ... employers, unions, and state employee plans, according to new ... Care Management Association (PCMA).   The use of these ...
Cached Medicine Technology:Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 2Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 3Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $617 Million in Wisconsin 2
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... Bard, Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. According ... a Final Order on September 10th that provides for ... Order notes that none of the affected plaintiffs has ...
(Date:9/15/2014)... large cohort analysis from the prospective Prostate, Lung, Colorectal ... who had moderate baldness affecting both the front and ... at a 40% increased risk of developing aggressive prostate ... poorer prognosis relative to non-aggressive prostate cancer) later in ... no significant link between other patterns of baldness and ...
(Date:9/15/2014)... The White House has recently begun shifting ... jail and prison and toward helping them access addiction ... positive change. , The nation is currently grappling with ... to an article from The Washington Post , ... away from using the criminal justice system to address ...
(Date:9/15/2014)... By Maureen Salamon ... (HealthDay News) -- Pediatricians prescribe antibiotics about twice as ... and throat infections, a new study indicates. More ... children and teens may be unnecessary, according to researchers ... excess antibiotic use not only fails to eradicate children,s ...
(Date:9/15/2014)... shown that certain brain regions are associated with ... decision-making. , How and where these specific abilities ... cognition is still under investigation. However, researchers at ... St. Louis, Missouri, believe that several hub regions ... function as an integrated network. , In research ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2Health News:White House Shifts Policy on Drugs 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Network measures predict neuropsychological outcome after brain injury 2
... its new patient-education website, www.CLIclinicalstudy.com , is now “live”. ... enrolling in the Company’s clinical trial and their referring physicians ... underlies it, and the location of the study’s sites. ... ...
... help consumers get,accurate, dependable information about healthcare ... support consumer,engagement and improved quality in healthcare, ... consumer-focused, internet-based public,reporting. These guidelines will assist ... in an evidence-based and,consumer-friendly format that can ...
... (October 26, 2008) A single administration of a novel, ... that were more than 20 times higher than those ... according to a study by NanoBio Corporation. The new ... produce this effect. , Results of the study are ...
... blood that was 29 days or older faced twice the ... who receive a transfusion of stored blood that is 29 ... or more serious infections compared to those who get "fresher" ... that current U.S. regulations set the upper limit for blood ...
... of candy, ST. LOUIS, Oct. 28 The ... year, and a sizeable portion of that indulgence,is eaten ... will,simply create an expanded beltline. However, for the more ... can pose more,tricky consequences., To help ease candy ...
... Resources to Prevent Millions in Lost Wages, SAN ... of the flu are reported annually, financially challenging working,families ... days. QuickHealth meets,the challenge by providing updated information and ... to clarify treatment options and to help,them make better ...
Cached Medicine News:Health News: Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 2Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 3Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 4Health News:NQF Endorses Guidelines for Consumer-Focused Public Reporting 5Health News:New intranasal influenza vaccine triggers robust immunity with significantly less antigen 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 3Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 2Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 3Health News:75 Million Missed Work Days Expected This Flu Season 2Health News:75 Million Missed Work Days Expected This Flu Season 3
... an ultra-capacity bacterial growth system, combines ... a high-capacity format for bacterial growth. ... with Bioneer's HT-Prep™ Automatic DNA Extractor. ... advantages over traditional floor shakers. Plate-holding ...
Inquire...
... Refrigerated incubators,Two refrigerated incubators ... life and life cycle,testing. Microprocessor ... digital temperature display. High/low audible ... contacts. Additional internal chamber safety ...
Inquire...
Medicine Products: